By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug ...

Railway marathon to honor Christina Chambers ...

Great thrillers like Prisoners and The Conversation are brilliant slow-burns, taking their time to set up the mystery and ...

McCOOK, Neb. - For the first Coffee Talk of 2026, the Gazette met with Ruby Collins and Samantha Daniel of the University of Nebraska Institute of Agriculture and Natural Resources Extension offices, ...

There’s no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to ...

Out of 93 potential Winter Olympic and Paralympic Games host sites only 52 would remain climate-reliable for the Olympics and ...

A queer horror film, a double dose of Olivia Wilde, a shocker about an 8-year-old sexual assault witness and docs on Salman ...

The interstellar visitor may still have a few things to tell us before it leaves our solar system.

Citations for parking in San Francisco bike lanes briefly rose early last year. Here's what's happened since.

The FDA has requested new human factors and pharmacology studies for Anaphylm sublingual film following deficiencies in original NDA packaging data.

When I was inside my cell, I heard wailing, screaming, crying, begging, and pleading from women, men, and children. Alongside that visceral anguish was the small talk, banter, and laughter from the ...

Aquestive Therapeutics announced it received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) for Anaphylm (dibutepinephrine) Sublingual Film, a noninvasive ...